Clinical Trial Update: Using Aspirin to Improve Immunological Features of Ovarian Tumors [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial is exploring whether aspirin can improve the immunological features of ovarian tumors and related cancers. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | EARLY_Phase 1 | Status: RECRUITING